Hepcidin levels and gastric cancer risk in the EPIC-EurGast study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bueno-de-Mesquita, H B As
Huerta, José María
Quirós, José Maria
Peeters, Petra H
MetadataShow full item record
TitleHepcidin levels and gastric cancer risk in the EPIC-EurGast study.
Published inInt J Cancer 2017; 141(5):945-51
PubliekssamenvattingHepcidin is the main regulator of iron homeostasis and dysregulation of proteins involved in iron metabolism has been associated with tumorogenesis. However, to date, no epidemiological study has researched the association between hepcidin levels and gastric cancer risk. To further investigate the relationship between hepcidin levels and gastric cancer risk, we conducted a nested case-control study (EURGAST) within the multicentric European Prospective Investigation into Cancer and Nutrition study. The study included 456 primary incident gastric adenocarcinoma cases and 900 matched controls that occurred during an average of 11 years of follow-up. We measured serum levels of hepcidin-25, iron, ferritin, transferrin and C-reactive protein. Odds ratios (ORs) and 95% confidence intervals (CIs) for the risk of gastric cancer by hepcidin levels were estimated from multivariable conditional logistic regression models. Mediation effect of the ferritin levels on the hepcidin-gastric cancer pathway was also evaluated. After adjusting for relevant confounders, we observed a statistically significant inverse association between gastric cancer and hepcidin levels (OR 5 ng/l = 0.96, 95% CI = 0.93-0.99). No differences were found by tumor localization or histological type. In mediation analysis, we found that the direct effect of hepcidin only represents a nonsignificant 38% (95% CI: -69%, 91%). In summary, these data suggest that the inverse association of hepcidin levels and gastric cancer risk was mostly accounted by ferritin levels. Further investigation including repeated measures of hepcidin is needed to clarify their role in gastric carcinogenesis.
- Body iron status and gastric cancer risk in the EURGAST study.
- Authors: Fonseca-Nunes A, Agudo A, Aranda N, Arija V, Cross AJ, Molina E, Sanchez MJ, Bueno-de-Mesquita HB, Siersema P, Weiderpass E, Krogh V, Mattiello A, Tumino R, Saieva C, Naccarati A, Ohlsson B, Sjöberg K, Boutron-Ruault MC, Cadeau C, Fagherazzi G, Boeing H, Steffen A, Kühn T, Katzke V, Tjønneland A, Olsen A, Khaw KT, Wareham N, Key T, Lu Y, Riboli E, Peeters PH, Gavrila D, Dorronsoro M, Quirós JR, Barricarte A, Jenab M, Zamora-Ros R, Freisling H, Trichopoulou A, Lagiou P, Bamia C, Jakszyn P
- Issue date: 2015 Dec 15
- Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
- Authors: Chajès V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjønneland A, Clavel-Chapelon F, Boutron-Ruault MC, Engel P, Teucher B, Kaaks R, Floegel A, Boeing H, Trichopoulou A, Dilis V, Karapetyan T, Mattiello A, Tumino R, Grioni S, Palli D, Vineis P, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Lund E, Navarro C, Quirós JR, Sánchez-Cantalejo E, Gurrea AB, Dorronsoro M, Regnér S, Sonestedt E, Wirfält E, Khaw KT, Wareham N, Allen NE, Crowe FL, Rinaldi S, Slimani N, Carneiro F, Riboli E, González CA
- Issue date: 2011 Nov
- Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study.
- Authors: Wisaksana R, de Mast Q, Alisjahbana B, Jusuf H, Sudjana P, Indrati AR, Sumantri R, Swinkels D, van Crevel R, van der Ven A
- Issue date: 2013
- Hepcidin and iron metabolism associated with cardiometabolic risk factors in children: A case-control study.
- Authors: Zhu YN, He BT, Jing J, Ma J, Li XH, Yang WH, Jin Y, Chen YJ
- Issue date: 2016 Jun
- Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus.
- Authors: Pechlaner R, Weiss G, Bansal S, Mayr M, Santer P, Pallhuber B, Notdurfter M, Bonora E, Willeit J, Kiechl S
- Issue date: 2016 Feb